Stockx

stockx

What is StockX?

StockX is an online marketplace and clothing reseller, primarily of sneakers. Since November 2020, it has also opened up to electronic products [1] such as game consoles, smartphones and computer hardware. The Detroit-based company was founded by Dan Gilbert, Josh Luber, Greg Schwartz, and Chris Kaufman in 2015–2016.

Where can I buy ontx stock?

Shares of ONTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.

What is the upside for Onconova Therapeuticsstock?

Their forecasts range from $7.00 to $12.00. On average, they expect Onconova Therapeutics stock price to reach $10.00 in the next year. This suggests a possible upside of 468.2% from the stocks current price. View analysts price targets for Onconova Therapeutics or view top-rated stocks among Wall Street analysts.

Why choose Onde?

Our experts will do everything to meet the needs of your business. Your city, your fleet, your language, your logo, your brand. All Onde products are humane and intuitive. Our system is easy to use. One action per click. Every time. For everyone. Onde makes payment processing and management as easy as pie.

How does StockX work?

StockX operates an online marketplace for buying and selling sneakers designed to trade high-demand and limited edition products. Buyers place bids, sellers place asks and when a bid and ask meet, the transaction happens automatically.

What is StockX’s business model?

Their business model is based on facilitating public auctions between buyers and sellers, while keeping the experience secure for all parties involved. Based in Detroit, MI, StockX employs more than 800 people at their headquarters. To take care of the item authentication process, they’ve opened several dedicated offices.

Does StockX sell fake products?

StockX does not sell fake products. The StockX platform aims to provide a safe place for you to shop and a safe place for sellers to know they will be paid for their authentic goods. The Detroit startup does not condone the sale of fake or illegal goods.

Is StockX the next big thing for shoe shops?

Fast forward to 2019, StockX is a billion-dollar company, one that is eyeing further expansion. Not bad for a shoe shop. Although it’s not just shoes any more – the site has expanded to handbags, watches and streetwear too.

Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Onconova Therapeutics stock price today? One share of ONTX stock can currently be purchased for approximately $1.76.

What does ontxs asset turnover ratio rank among pharmaceutical products stocks?

What has happened to Onconova Therapeutics stock?

Since then, ONTX stock has decreased by 67.4% and is now trading at $1.76. View which stocks have been most impacted by COVID-19. Are investors shorting Onconova Therapeutics? Onconova Therapeutics saw a decrease in short interest in the month of February.

What does Onconova Therapeuticss P/E ratio mean?

The P/E ratio of Onconova Therapeutics is -1.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Onconova Therapeutics is -1.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Who is the new director of Corporate Development at Onconova?

NEWTOWN, Pa., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that Dr. Adar Makovski Silverstein has joined Onconova as Director, Corporate Development.

How do I contact Onconova?

The biopharmaceutical company can be reached via phone at (267) 759-3680, via email at ir@onconova.us, or via fax at 267-759-3681. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.

Postagens relacionadas: